Annual FCF
-$27.64 M
-$29.20 M-1875.59%
December 31, 2023
Summary
- As of February 6, 2025, CAPR annual free cash flow is -$27.64 million, with the most recent change of -$29.20 million (-1875.59%) on December 31, 2023.
- During the last 3 years, CAPR annual FCF has fallen by -$17.04 million (-160.73%).
- CAPR annual FCF is now -1875.59% below its all-time high of $1.56 million, reached on December 31, 2022.
Performance
CAPR Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$11.70 M
+$667.90 K+5.40%
September 30, 2024
Summary
- As of February 6, 2025, CAPR quarterly free cash flow is -$11.70 million, with the most recent change of +$667.90 thousand (+5.40%) on September 30, 2024.
- Over the past year, CAPR quarterly FCF has increased by +$667.90 thousand (+5.40%).
- CAPR quarterly FCF is now -149.96% below its all-time high of $23.42 million, reached on March 31, 2022.
Performance
CAPR Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$38.33 M
-$2.27 M-6.31%
September 30, 2024
Summary
- As of February 6, 2025, CAPR TTM free cash flow is -$38.33 million, with the most recent change of -$2.27 million (-6.31%) on September 30, 2024.
- Over the past year, CAPR TTM FCF has dropped by -$2.27 million (-6.31%).
- CAPR TTM FCF is now -536.44% below its all-time high of $8.78 million, reached on March 31, 2022.
Performance
CAPR TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
CAPR Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -1875.6% | +5.4% | -6.3% |
| 3 y3 years | -160.7% | -44.0% | -2561.8% |
| 5 y5 years | -95.0% | -44.0% | -2561.8% |
CAPR Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -1875.6% | at low | -150.0% | +5.4% | -536.4% | at low |
| 5 y | 5-year | -1875.6% | at low | -150.0% | +5.4% | -536.4% | at low |
| alltime | all time | -1875.6% | at low | -150.0% | +5.4% | -536.4% | at low |
Capricor Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$11.70 M(-5.4%) | -$38.33 M(+6.3%) |
| Jun 2024 | - | -$12.37 M(+540.0%) | -$36.05 M(+8.2%) |
| Mar 2024 | - | -$1.93 M(-84.3%) | -$33.33 M(+20.6%) |
| Dec 2023 | -$27.64 M(-1875.6%) | -$12.32 M(+30.7%) | -$27.64 M(+17.9%) |
| Sep 2023 | - | -$9.43 M(-2.3%) | -$23.45 M(+12.7%) |
| Jun 2023 | - | -$9.65 M(-356.9%) | -$20.80 M(+14.9%) |
| Mar 2023 | - | $3.76 M(-146.2%) | -$18.11 M(-1263.0%) |
| Dec 2022 | $1.56 M(-108.6%) | -$8.12 M(+19.7%) | $1.56 M(-57.8%) |
| Sep 2022 | - | -$6.78 M(-2.4%) | $3.69 M(-44.7%) |
| Jun 2022 | - | -$6.95 M(-129.7%) | $6.66 M(-24.1%) |
| Mar 2022 | - | $23.42 M(-490.6%) | $8.78 M(-148.8%) |
| Dec 2021 | -$18.01 M(+69.8%) | -$6.00 M(+57.5%) | -$18.01 M(+11.6%) |
| Sep 2021 | - | -$3.81 M(-21.3%) | -$16.14 M(+4.4%) |
| Jun 2021 | - | -$4.84 M(+43.7%) | -$15.46 M(+21.3%) |
| Mar 2021 | - | -$3.37 M(-18.5%) | -$12.75 M(+20.3%) |
| Dec 2020 | -$10.60 M(+55.4%) | -$4.13 M(+32.0%) | -$10.60 M(+28.4%) |
| Sep 2020 | - | -$3.13 M(+47.3%) | -$8.26 M(+21.8%) |
| Jun 2020 | - | -$2.12 M(+74.4%) | -$6.78 M(+5.4%) |
| Mar 2020 | - | -$1.22 M(-31.8%) | -$6.43 M(-5.7%) |
| Dec 2019 | -$6.82 M(-51.9%) | -$1.78 M(+8.1%) | -$6.82 M(-22.4%) |
| Sep 2019 | - | -$1.65 M(-7.1%) | -$8.79 M(-14.4%) |
| Jun 2019 | - | -$1.78 M(+10.6%) | -$10.27 M(-15.7%) |
| Mar 2019 | - | -$1.61 M(-57.2%) | -$12.18 M(-14.1%) |
| Dec 2018 | -$14.18 M(-0.6%) | -$3.76 M(+20.1%) | -$14.18 M(+8.3%) |
| Sep 2018 | - | -$3.13 M(-15.3%) | -$13.09 M(-0.6%) |
| Jun 2018 | - | -$3.69 M(+2.4%) | -$13.17 M(-0.1%) |
| Mar 2018 | - | -$3.60 M(+35.1%) | -$13.19 M(-7.5%) |
| Dec 2017 | -$14.26 M(-2.6%) | -$2.67 M(-16.8%) | -$14.26 M(-6.0%) |
| Sep 2017 | - | -$3.21 M(-13.6%) | -$15.18 M(+9.2%) |
| Jun 2017 | - | -$3.71 M(-20.7%) | -$13.90 M(-8.0%) |
| Mar 2017 | - | -$4.68 M(+30.6%) | -$15.10 M(+3.1%) |
| Dec 2016 | -$14.65 M(+33.5%) | -$3.58 M(+86.4%) | -$14.65 M(-0.4%) |
| Sep 2016 | - | -$1.92 M(-60.9%) | -$14.71 M(-8.7%) |
| Jun 2016 | - | -$4.92 M(+16.3%) | -$16.12 M(+23.0%) |
| Mar 2016 | - | -$4.23 M(+15.9%) | -$13.11 M(+19.5%) |
| Dec 2015 | -$10.97 M(-1520.6%) | -$3.65 M(+9.5%) | -$10.97 M(+15.7%) |
| Sep 2015 | - | -$3.33 M(+75.2%) | -$9.48 M(+12.8%) |
| Jun 2015 | - | -$1.90 M(-9.0%) | -$8.40 M(-33.1%) |
| Mar 2015 | - | -$2.09 M(-3.4%) | -$12.57 M(-1727.4%) |
| Dec 2014 | $772.10 K(-112.5%) | -$2.16 M(-4.0%) | $772.20 K(-75.5%) |
| Sep 2014 | - | -$2.25 M(-62.9%) | $3.15 M(+266.8%) |
| Jun 2014 | - | -$6.06 M(-153.9%) | $858.10 K(-86.2%) |
| Mar 2014 | - | $11.25 M(+5186.7%) | $6.24 M(-200.6%) |
| Dec 2013 | -$6.20 M(+186.3%) | $212.80 K(-104.7%) | -$6.20 M(-5.0%) |
| Sep 2013 | - | -$4.54 M(+566.7%) | -$6.52 M(+163.3%) |
| Jun 2013 | - | -$681.20 K(-42.8%) | -$2.48 M(-6.5%) |
| Mar 2013 | - | -$1.19 M(+964.7%) | -$2.65 M(+28.4%) |
| Dec 2012 | -$2.17 M | -$111.80 K(-77.4%) | -$2.06 M(-41.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2012 | - | -$494.70 K(-42.0%) | -$3.52 M(-4.3%) |
| Jun 2012 | - | -$852.80 K(+41.3%) | -$3.68 M(-7.9%) |
| Mar 2012 | - | -$603.50 K(-61.5%) | -$3.99 M(-14.1%) |
| Dec 2011 | -$4.65 M(+7.7%) | -$1.57 M(+140.4%) | -$4.65 M(+12.4%) |
| Sep 2011 | - | -$652.50 K(-44.1%) | -$4.14 M(-10.4%) |
| Jun 2011 | - | -$1.17 M(-7.4%) | -$4.62 M(+4.5%) |
| Mar 2011 | - | -$1.26 M(+19.4%) | -$4.42 M(+2.3%) |
| Dec 2010 | -$4.32 M(-25.9%) | -$1.06 M(-6.9%) | -$4.32 M(-1.5%) |
| Sep 2010 | - | -$1.13 M(+17.3%) | -$4.39 M(+3.7%) |
| Jun 2010 | - | -$966.70 K(-16.8%) | -$4.23 M(-17.1%) |
| Mar 2010 | - | -$1.16 M(+3.6%) | -$5.10 M(-12.5%) |
| Dec 2009 | -$5.83 M(-45.7%) | -$1.12 M(+14.6%) | -$5.83 M(-11.3%) |
| Sep 2009 | - | -$979.30 K(-46.7%) | -$6.57 M(-23.4%) |
| Jun 2009 | - | -$1.84 M(-3.0%) | -$8.58 M(-14.7%) |
| Mar 2009 | - | -$1.89 M(+1.6%) | -$10.05 M(-6.3%) |
| Dec 2008 | -$10.73 M(+89.6%) | -$1.86 M(-37.6%) | -$10.73 M(+0.5%) |
| Sep 2008 | - | -$2.98 M(-9.9%) | -$10.68 M(+10.2%) |
| Jun 2008 | - | -$3.31 M(+28.7%) | -$9.69 M(+33.7%) |
| Mar 2008 | - | -$2.57 M(+42.5%) | -$7.25 M(+28.0%) |
| Dec 2007 | -$5.66 M(+185.5%) | -$1.81 M(-9.6%) | -$5.66 M(-1.2%) |
| Sep 2007 | - | -$2.00 M(+130.6%) | -$5.73 M(+51.6%) |
| Jun 2007 | - | -$866.70 K(-12.5%) | -$3.78 M(+29.7%) |
| Mar 2007 | - | -$990.30 K(-47.1%) | -$2.91 M(+51.1%) |
| Dec 2006 | -$1.98 M(>+9900.0%) | -$1.87 M(+3827.9%) | -$1.93 M(+3202.7%) |
| Sep 2006 | - | -$47.70 K(+1973.9%) | -$58.40 K(+320.1%) |
| Jun 2006 | - | -$2300.00(-55.8%) | -$13.90 K(-5.4%) |
| Mar 2006 | - | -$5200.00(+62.5%) | -$14.70 K(-17.4%) |
| Dec 2005 | -$17.80 K(+14.8%) | -$3200.00(0.0%) | -$17.80 K(-7.3%) |
| Sep 2005 | - | -$3200.00(+3.2%) | -$19.20 K(-1.0%) |
| Jun 2005 | - | -$3100.00(-62.7%) | -$19.40 K(-9.3%) |
| Mar 2005 | - | -$8300.00(+80.4%) | -$21.40 K(+38.1%) |
| Dec 2004 | -$15.50 K(-25.5%) | -$4600.00(+35.3%) | -$15.50 K(+8.4%) |
| Sep 2004 | - | -$3400.00(-33.3%) | -$14.30 K(+5.9%) |
| Jun 2004 | - | -$5100.00(+112.5%) | -$13.50 K(-29.3%) |
| Mar 2004 | - | -$2400.00(-29.4%) | -$19.10 K(-8.2%) |
| Dec 2003 | -$20.80 K(+45.5%) | -$3400.00(+30.8%) | -$20.80 K(+7.2%) |
| Sep 2003 | - | -$2600.00(-75.7%) | -$19.40 K(-7.6%) |
| Jun 2003 | - | -$10.70 K(+161.0%) | -$21.00 K(-13.9%) |
| Mar 2003 | - | -$4100.00(+105.0%) | -$24.40 K(+69.4%) |
| Dec 2002 | -$14.30 K(+10.0%) | -$2000.00(-52.4%) | -$14.40 K(+10.8%) |
| Sep 2002 | - | -$4200.00(-70.2%) | -$13.00 K(+34.0%) |
| Jun 2002 | - | -$14.10 K(-339.0%) | -$9700.00(-446.4%) |
| Mar 2002 | - | $5900.00(-1083.3%) | $2800.00(-121.4%) |
| Dec 2001 | -$13.00 K(-65.1%) | -$600.00(-33.3%) | -$13.10 K(+4.8%) |
| Sep 2001 | - | -$900.00(-43.8%) | -$12.50 K(+7.8%) |
| Jun 2001 | - | -$1600.00(-84.0%) | -$11.60 K(+16.0%) |
| Mar 2001 | - | -$10.00 K | -$10.00 K |
| Dec 2000 | -$37.30 K(<-9900.0%) | - | - |
| Dec 1999 | $0.00 | - | - |
FAQ
- What is Capricor Therapeutics annual free cash flow?
- What is the all time high annual FCF for Capricor Therapeutics?
- What is Capricor Therapeutics annual FCF year-on-year change?
- What is Capricor Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Capricor Therapeutics?
- What is Capricor Therapeutics quarterly FCF year-on-year change?
- What is Capricor Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Capricor Therapeutics?
- What is Capricor Therapeutics TTM FCF year-on-year change?
What is Capricor Therapeutics annual free cash flow?
The current annual FCF of CAPR is -$27.64 M
What is the all time high annual FCF for Capricor Therapeutics?
Capricor Therapeutics all-time high annual free cash flow is $1.56 M
What is Capricor Therapeutics annual FCF year-on-year change?
Over the past year, CAPR annual free cash flow has changed by -$29.20 M (-1875.59%)
What is Capricor Therapeutics quarterly free cash flow?
The current quarterly FCF of CAPR is -$11.70 M
What is the all time high quarterly FCF for Capricor Therapeutics?
Capricor Therapeutics all-time high quarterly free cash flow is $23.42 M
What is Capricor Therapeutics quarterly FCF year-on-year change?
Over the past year, CAPR quarterly free cash flow has changed by +$667.90 K (+5.40%)
What is Capricor Therapeutics TTM free cash flow?
The current TTM FCF of CAPR is -$38.33 M
What is the all time high TTM FCF for Capricor Therapeutics?
Capricor Therapeutics all-time high TTM free cash flow is $8.78 M
What is Capricor Therapeutics TTM FCF year-on-year change?
Over the past year, CAPR TTM free cash flow has changed by -$2.27 M (-6.31%)